Epidemiology — MCQs

In a prospective study comprising 10,000 subjects, 6000 subjects were assigned to receive beta carotene and 4000 were not. Three out of the 6000 subjects receiving beta carotene developed lung cancer, and two out of the 4000 subjects not receiving beta carotene developed lung cancer. What is the interpretation of these results?

Q658Easy

While analyzing data, allocation into similar groups is done to ensure what?

Q659Easy

What is the most significant indicator of fertility?

Q660Easy

What is the analysis of routine measurements aimed at detecting changes in the environment known as?

Epidemiology Indian Medical PG Practice Questions and MCQs

Question 651: What is the most common cause of death in developed countries?

A. Ischemic heart disease (Correct Answer)
B. Accidents
C. Infectious disease
D. None of the above

Explanation: **Explanation:** **Correct Answer: A. Ischemic Heart Disease (IHD)** In developed countries, the epidemiological transition has shifted the burden of disease from communicable to non-communicable diseases (NCDs). Ischemic Heart Disease (also known as Coronary Artery Disease) is currently the leading cause of mortality globally and specifically in developed nations. This is attributed to increased life expectancy, sedentary lifestyles, and high prevalence of metabolic risk factors such as hypertension, hyperlipidemia, and obesity. According to the WHO Global Health Estimates, IHD remains the "World’s Biggest Killer," accounting for approximately 16% of total deaths worldwide. **Analysis of Incorrect Options:** * **B. Accidents:** While road traffic accidents (RTAs) and unintentional injuries are a significant cause of death among the younger population (ages 15–29), they do not surpass the total mortality rate of cardiovascular diseases in the general population of developed countries. * **C. Infectious disease:** These were the leading cause of death historically. However, due to advancements in sanitation, immunization, and antibiotics, infectious diseases now account for a much smaller fraction of mortality in developed nations compared to developing or low-income countries. **High-Yield Clinical Pearls for NEET-PG:** * **Global Burden:** IHD is the #1 cause of death worldwide. * **Developing Countries:** While infectious diseases are still prevalent, NCDs (led by IHD) are rapidly becoming the leading cause of death here as well (Double Burden of Disease). * **Most Common Cancer Death:** Globally, Lung Cancer is the leading cause of cancer-related mortality in both developed and developing regions. * **Leading Disability-Adjusted Life Years (DALYs):** IHD is also a top contributor to the global DALYs.

Question 652: In the natural history of disease, all are true about the period of pathogenesis, EXCEPT:

A. Occurs after the agent enters the host body
B. Tertiary prevention is possible at this stage
C. Screening does not affect the course of the phase (Correct Answer)
D. A sub-clinical phase can be present

Explanation: In the natural history of disease, the **Pathogenesis Phase** begins the moment the disease agent enters a susceptible human host. ### Why Option C is the Correct Answer (The Exception) Screening is a core component of **Secondary Prevention**. Its primary objective is the early detection of disease during the sub-clinical or early symptomatic stage of the pathogenesis phase. By identifying the disease early, medical intervention can halt the progression, prevent complications, and significantly alter the clinical course. Therefore, stating that screening "does not affect the course" is factually incorrect. ### Analysis of Other Options * **A. Occurs after the agent enters the host body:** This is the definition of pathogenesis. It contrasts with the *Pre-pathogenesis phase*, where the agent, host, and environment exist but have not yet interacted within the human body. * **B. Tertiary prevention is possible at this stage:** Tertiary prevention (disability limitation and rehabilitation) occurs during the late stages of pathogenesis to reduce the impact of long-term disease or permanent impairment. * **C. A sub-clinical phase can be present:** Pathogenesis is divided into the **pre-symptomatic (sub-clinical)** phase, where physiological changes occur without visible symptoms, and the **clinical phase**, where signs and symptoms appear. ### NEET-PG High-Yield Pearls * **Pre-pathogenesis:** Corresponds to **Primary Prevention** (Health promotion and Specific protection). * **Pathogenesis:** Corresponds to **Secondary Prevention** (Early diagnosis and Treatment) and **Tertiary Prevention**. * **Biological Onset:** The exact point where pathogenesis begins; often occurs long before the "Clinical Horizon" (the point where symptoms become manifest). * **Screening:** Aims to shift the diagnosis to the left of the clinical horizon.

Question 653: Urban malaria is caused by which of the following mosquitoes?

A. Anopheles culicifacies
B. Phlebotomus
C. Anopheles stephensi (Correct Answer)
D. Aedes

Explanation: **Explanation:** The correct answer is **Anopheles stephensi**. In India, the epidemiology of malaria is largely defined by the specific breeding habits of its vectors. **Why Anopheles stephensi is correct:** *Anopheles stephensi* is the primary vector for **Urban Malaria**. It has adapted to urban environments by breeding in artificial containers, overhead water tanks, cisterns, fountain basins, and construction sites. Its ability to thrive in clean, stagnant water found in man-made structures makes it the dominant vector in cities. **Analysis of Incorrect Options:** * **A. Anopheles culicifacies:** This is the most important vector for **Rural Malaria** in India. It breeds in rainwater pools, irrigation channels, and borrow pits. It is responsible for nearly 60-70% of total malaria cases in the country, primarily in rural settings. * **B. Phlebotomus:** This is the Sandfly, which is the vector for **Kala-azar** (Visceral Leishmaniasis) and Oriental Sore, not malaria. * **C. Aedes:** *Aedes aegypti* and *Aedes albopictus* are vectors for **Dengue, Chikungunya, and Zika virus**. They are "day-biters" and breed in artificial containers, but they do not transmit malaria. **High-Yield Clinical Pearls for NEET-PG:** * **Major Vectors in India:** * **Rural:** *An. culicifacies* * **Urban:** *An. stephensi* * **Hills/Forests:** *An. fluviatilis* * **North-East India:** *An. minimus* and *An. dirus* * **Urban Malaria Scheme (UMS):** Launched in 1971, it focuses on anti-larval measures (source reduction) because urban vectors breed in accessible man-made containers. * **Feeding Habit:** Most Anopheles mosquitoes are **nocturnal** (night-biters), whereas Aedes are diurnal.

Question 654: A study surveyed 3500 patients with thyroid cancer regarding their past exposure to radiation. The study design most appropriately illustrates which of the following?

A. Case series report (Correct Answer)
B. Case control study
C. Case report
D. Clinical trial

Explanation: **Explanation:** The correct answer is **Case series report (Option A)**. In this scenario, the researchers are looking at a group of 3500 patients who already have the disease (thyroid cancer) and are documenting their history of exposure. A **Case Series** is a descriptive study design that describes the characteristics of a group of individuals with a common disease or exposure. It does not utilize a control group, making it purely descriptive rather than analytical. **Why other options are incorrect:** * **Case-control study (B):** This requires a **comparison group** (controls) of people without thyroid cancer to compare the frequency of radiation exposure. Since no control group is mentioned, it cannot be a case-control study. * **Case report (C):** A case report describes a single patient or a very small number of patients (usually <10) with a unique or unusual presentation. A sample size of 3500 is far too large for a case report. * **Clinical trial (D):** This is an interventional study where the researcher assigns an exposure (like a drug). In this scenario, the exposure (radiation) happened in the past, and the study is observational. **Clinical Pearls for NEET-PG:** * **Hierarchy of Evidence:** Case reports and case series are at the bottom of the evidence pyramid because they lack a control group. * **Key Identifier:** If a question describes a group of diseased individuals without a comparison group, it is a **Case Series**. * **Utility:** Case series are excellent for identifying the emergence of new diseases or rare side effects but cannot prove **causality** or calculate **Relative Risk/Odds Ratio**. * **Directionality:** Case series are retrospective in nature (looking back at history/records).

Question 655: Study of time, place, and person is called as?

A. Experimental epidemiology
B. Analytical epidemiology
C. Descriptive epidemiology (Correct Answer)
D. Randomized controlled trial

Explanation: ### Explanation **1. Why Descriptive Epidemiology is Correct:** Descriptive epidemiology is the first step in an epidemiological investigation. It focuses on describing the occurrence and distribution of a disease in a population. It answers the fundamental questions of **Who** (Person), **Where** (Place), and **When** (Time). * **Time:** Trends, seasonal variations, or cyclic patterns. * **Place:** Geographic distribution (urban vs. rural, local vs. international). * **Person:** Characteristics like age, sex, occupation, and socio-economic status. The primary outcome of descriptive epidemiology is the **formulation of a hypothesis**. **2. Why Other Options are Incorrect:** * **Analytical Epidemiology (Option B):** This step goes beyond description to test the hypothesis formulated in descriptive studies. It focuses on the **"Why"** and **"How"** (determinants) by comparing a study group with a control group (e.g., Case-control or Cohort studies). * **Experimental Epidemiology (Option A):** This involves the deliberate manipulation of the study factor (e.g., giving a drug vs. a placebo) to confirm the etiology of a disease or the efficacy of a treatment. * **Randomized Controlled Trial (Option D):** This is a specific type of experimental study design, often considered the "gold standard" for testing new interventions. It is a subset of experimental epidemiology, not a study of time, place, and person. **3. High-Yield Clinical Pearls for NEET-PG:** * **Sequence of Epidemiology:** Descriptive (Hypothesis formulation) → Analytical (Hypothesis testing) → Experimental (Hypothesis confirmation). * **The Epidemiological Triad:** Agent, Host, and Environment (distinct from the "Time, Place, Person" triad). * **Key Metric:** Descriptive epidemiology often uses **Prevalence**, while Analytical epidemiology (specifically Cohort studies) measures **Incidence**.

Question 656: Which of the following is NOT included in the 'SAFE' strategy?

A. Supplementation of vitamins (Correct Answer)
B. Antibiotics
C. Face washing
D. Improvement of the environment

Explanation: The **SAFE strategy** is a comprehensive public health approach recommended by the World Health Organization (WHO) for the elimination of **Trachoma**, the leading infectious cause of blindness worldwide. ### **Why "Supplementation of vitamins" is the correct answer:** Vitamin supplementation (specifically Vitamin A) is a core strategy for preventing Xerophthalmia and nutritional blindness, but it is **not** a component of the SAFE strategy. Trachoma is caused by *Chlamydia trachomatis* (serotypes A, B, Ba, and C), and its management focuses on surgical intervention, infection control, and hygiene rather than nutritional support. ### **Explanation of the SAFE Components:** * **S - Surgery:** To treat the blinding stage of the disease (Trachomatous Trichiasis) by correcting inward-turning eyelashes. * **A - Antibiotics:** Specifically the use of **Azithromycin** (single oral dose) or Tetracycline eye ointment to treat the active infection and reduce the community reservoir. * **F - Facial cleanliness:** Encouraging regular face washing, especially in children, to reduce the transmission of infected ocular and nasal secretions. * **E - Environmental improvement:** Improving access to water and sanitation (e.g., latrine construction) to reduce the population of **Musca sorbens** (eye-seeking flies) that act as vectors. ### **High-Yield Facts for NEET-PG:** * **Target:** The WHO "GET2020" initiative aimed to eliminate trachoma by 2020. * **Vector:** The common housefly (*Musca domestica*) and the eye-seeking fly (*Musca sorbens*). * **Drug of Choice:** Azithromycin (20 mg/kg up to 1g). * **India Status:** India was declared free from **infective trachoma** in 2017, though surveillance for trichiasis continues.

Question 657: In a prospective study comprising 10,000 subjects, 6000 subjects were assigned to receive beta carotene and 4000 were not. Three out of the 6000 subjects receiving beta carotene developed lung cancer, and two out of the 4000 subjects not receiving beta carotene developed lung cancer. What is the interpretation of these results?

A. Beta carotene is protective against lung cancer.
B. Beta carotene and lung cancer have no statistically significant relation. (Correct Answer)
C. The study design is not sufficient to draw any meaningful conclusions.
D. Beta carotene is carcinogenic.

Explanation: ### Explanation **1. Why the Correct Answer is Right:** To interpret the relationship between an exposure (beta carotene) and an outcome (lung cancer), we must calculate the **Incidence** or **Relative Risk (RR)**. * **Incidence in Exposed Group (Ie):** $3 / 6,000 = 0.0005$ (or 0.5 per 1000) * **Incidence in Non-Exposed Group (Io):** $2 / 4,000 = 0.0005$ (or 0.5 per 1000) * **Relative Risk (RR):** $Ie / Io = 0.0005 / 0.0005 = 1.0$ In epidemiology, an **RR of 1.0** indicates that the incidence of the disease is identical in both groups. This signifies **no association** between the exposure and the outcome. Since there is no difference in risk, the relationship is not statistically significant. **2. Why the Incorrect Options are Wrong:** * **Option A (Protective):** For a factor to be protective, the RR must be **less than 1** (Incidence in exposed < Incidence in non-exposed). * **Option D (Carcinogenic):** For a factor to be a risk factor/carcinogen, the RR must be **greater than 1** (Incidence in exposed > Incidence in non-exposed). * **Option C (Insufficient Design):** A prospective study (Cohort study) with 10,000 subjects is a robust design for calculating incidence and relative risk; the data provided is sufficient to determine the lack of association. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Relative Risk (RR):** Best measure of strength of association in Cohort studies. * **RR = 1:** No association. * **RR > 1:** Positive association (Risk factor). * **RR < 1:** Negative association (Protective factor). * **CARET Study Note:** While this mathematical problem shows no association, real-world clinical trials (like the CARET study) actually found that high-dose beta carotene supplementation *increased* the risk of lung cancer in smokers (RR > 1). Always prioritize the provided data in mathematical questions.

Question 658: While analyzing data, allocation into similar groups is done to ensure what?

A. Comparability (Correct Answer)
B. Accuracy
C. Validity
D. Sensitivity

Explanation: ### Explanation **1. Why Comparability is Correct:** In epidemiological studies, particularly in **Randomized Controlled Trials (RCTs)** and **Case-Control studies**, the primary goal of allocation (randomization or matching) is to ensure that the study and control groups are as similar as possible in all respects except for the intervention or exposure being studied. This process ensures **Comparability**. When groups are comparable, any difference in the outcome can be confidently attributed to the intervention rather than to baseline differences or "confounding variables." **2. Analysis of Incorrect Options:** * **Accuracy:** Refers to how close a measurement is to the true value. While proper allocation reduces bias, accuracy is more closely related to the precision of instruments and data collection methods. * **Validity:** This is a broader term. While comparability contributes to *Internal Validity* (the degree to which the results are true for the study population), allocation itself is the specific mechanism used to achieve the prerequisite state of comparability. * **Sensitivity:** This is a measure of a screening or diagnostic test's ability to correctly identify those with the disease (True Positives). It is unrelated to the grouping of subjects in data analysis. **3. NEET-PG High-Yield Pearls:** * **Randomization** is the "heart" of an RCT because it eliminates **selection bias** and ensures comparability of both known and unknown confounders. * **Matching** is the technique used in Case-Control studies to ensure comparability between cases and controls. * **Confounding** occurs when the groups are *not* comparable, leading to a distortion of the true association between exposure and outcome. * **Blinding** is done to maintain the integrity of the study *after* allocation, whereas **Allocation** is done to ensure baseline similarity.

Question 659: What is the most significant indicator of fertility?

A. Net reproductive rate (Correct Answer)
B. Family size
C. Gross reproduction rate
D. General fertility rate

Explanation: **Explanation:** The **Net Reproductive Rate (NRR)** is considered the most significant indicator of fertility because it accounts for both **fertility and mortality**. It is defined as the number of daughters a newborn girl will bear during her lifetime, assuming fixed age-specific fertility and mortality rates. An NRR of 1.0 is the demographic goal for population stabilization (Replacement Level Fertility), as it implies that each mother is being replaced by exactly one daughter who survives to reproductive age. **Analysis of Options:** * **A. Net Reproductive Rate (Correct):** Unlike other indicators, it incorporates the survival probability of the female child until she reaches her own reproductive years, making it the most accurate measure of a population's self-replacement capacity. * **B. Family Size:** This is a descriptive term referring to the total number of children born to an individual woman. It is a retrospective measure and does not account for demographic trends or replacement levels. * **C. Gross Reproduction Rate (GRR):** This measures the average number of daughters born to a woman if she survives to the end of her reproductive life. It is less accurate than NRR because it **ignores mortality** (assumes all women survive until age 45-49). * **D. General Fertility Rate (GFR):** This is the number of live births per 1,000 women in the reproductive age group (15-44 or 49 years). While better than the Crude Birth Rate, it is a cross-sectional measure of current fertility rather than a generational replacement indicator. **High-Yield Facts for NEET-PG:** * **NRR = 1** is the target for the National Health Policy to achieve population stabilization. * When NRR is 1, the **Net Reproduction Rate** corresponds to a **CBR (Crude Birth Rate)** of approximately 21 per 1000. * **Total Fertility Rate (TFR)** is considered the best indicator of the *current* fertility trend, but NRR remains the most significant for *future* population growth and replacement.

Question 660: What is the analysis of routine measurements aimed at detecting changes in the environment known as?

A. Monitoring (Correct Answer)
B. Surveillance
C. Isolation
D. Randomized Controlled Trial

Explanation: **Explanation:** **Why Monitoring is Correct:** Monitoring refers to the **performance and analysis of routine measurements** aimed at detecting changes in the environment or health status of a population. It is a continuous process that measures the performance of an activity to ensure it is proceeding according to plan. In environmental health, this involves tracking levels of pollutants (e.g., air quality index or water chlorine levels) to ensure they remain within safe limits. **Analysis of Incorrect Options:** * **Surveillance:** While often confused with monitoring, surveillance is the continuous **scrutiny** of all aspects of occurrence and spread of a disease that are pertinent to effective control. It is broader and involves data collection, analysis, and **action** (e.g., Integrated Disease Surveillance Programme). * **Isolation:** This is a clinical intervention where an infected individual is separated from others during the period of communicability to prevent the direct or indirect transmission of the infectious agent. * **Randomized Controlled Trial (RCT):** This is an analytical epidemiological study design used to test the efficacy of a new drug or intervention. It is not a routine measurement of the environment. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring vs. Surveillance:** Monitoring is a sub-component of surveillance. Monitoring tracks the *process*, while surveillance tracks the *outcome* and involves a feedback loop for action. * **Sentinel Surveillance:** A method used when notification data is silent; it identifies "missing cases" to estimate the total health problem in a community. * **Key Distinction:** If the question mentions "routine measurements" or "performance of an activity," think **Monitoring**. If it mentions "continuous scrutiny" or "distribution of disease," think **Surveillance**.

Practice by Chapter

Principles of Epidemiology

Practice Questions

Measures of Disease Frequency

Practice Questions

Epidemiological Study Designs

Practice Questions

Descriptive Epidemiology

Practice Questions

Analytical Epidemiology

Practice Questions

Experimental Epidemiology

Practice Questions

Screening for Disease

Practice Questions

Surveillance Systems

Practice Questions

Investigation of an Epidemic

Practice Questions

Association and Causation

Practice Questions

Modern Epidemiological Methods

Practice Questions

Critical Appraisal of Epidemiological Studies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free